only the small subgroup of patients with initially elevated plasma beta tg levels ( greater than 20 ng/ml ) also scrutinized for hidden nsaid consumption or technical bias ( exclusion of data with serum txb2 less than or equal to 10000 pg/100 microliters and/or plasma pf4 greater than 10 ng/ml ) had significantly lower plasma beta tg levels ( -22.7 % ) than the pre-medication values after treatment with ketanserin , but not with placebo .
C0229671
serum
C0032105
plasma